TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

TIGIT blockade repolarizes AML-associated TIGIT⁺ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis

Online download statistics by month:

Online download statistics by month: December 2022 to August 2024

	Abstract	Full	Pdf
Dec 2022	275	281	129
Jan 2023	246	249	159
Feb 2023	157	158	82
Mar 2023	102	102	78
Apr 2023	68	68	51
May 2023	110	112	66
Jun 2023	86	86	64
Jul 2023	101	102	65
Aug 2023	104	106	75
Sep 2023	89	89	70
Oct 2023	112	112	69
Nov 2023	91	91	57
Dec 2023	93	93	76
Jan 2024	126	127	111
Feb 2024	68	68	61
Mar 2024	133	133	140
Apr 2024	113	116	106
May 2024	100	102	83
Jun 2024	145	147	99
Jul 2024	103	103	78
Aug 2024	88	87	57
Total	2510	2532	1776